Physician profile
David Steinberg
NPI 1649335043
$1,033.38
in general payments reported to CMS, 2019-2025
13 companies · $77.53 in 2025
The $77.53 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $297 · 2020: $105 · 2021: $110 · 2022: $131 · 2023: $189 · 2024: $125 · 2025: $77.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $246.58 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Abbvie INC. | $196.91 | 2019-2022 | |
| Glaxosmithkline, LLC. | $112.72 | 2019-2023 | Rotarix, Bexsero, Pediarix |
| Sanofi Pasteur INC. | $76.02 | 2019-2023 | |
| Organon LLC | $73.83 | 2021-2022 | |
| Allergan, INC. | $73.07 | 2019 | |
| Sobi, INC | $63.05 | 2020-2021 | |
| Lilly USA, LLC | $55.15 | 2024-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $45.39 | 2023 | |
| Coopersurgical, INC. | $34.22 | 2022 | |
| Sumitomo Pharma America, INC. | $21.57 | 2024 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $19.38 | 2023 | |
| Abbott Laboratories | $15.49 | 2024 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Steinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.